Advertisement

Modern Immunosuppressives

  • Henk-Jan Schuurman
  • Gilles Feutren
  • Jean-François Bach

Part of the Milestones in Drug Therapy MDT book series (MDT)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Introduction, global perspectives and history of immunosuppression

  3. Immunosuppressive drugs

    1. Front Matter
      Pages 9-9
    2. Gary A. Levy, Gerard F. Murphy, Paul A. Keown
      Pages 11-28
    3. Suphamai Bunnapradist, Gabriel Danovitch
      Pages 29-41
    4. Johnny C. Hong, Barry D. Kahan
      Pages 43-75
    5. Christophe Legendre, Eric Thervet
      Pages 77-96
  4. Biologicals

    1. Front Matter
      Pages 97-97
    2. Lucienne Chatenoud, Jean-François Bach
      Pages 99-113
  5. New avenues in immunosuppression

    1. Front Matter
      Pages 123-123
    2. Pekka Häyry, Hanna Savolainen, Serdar Yilmaz, Einari Aavik
      Pages 125-148
    3. Stuart J. Knechtle, Majed M. Hamawy
      Pages 149-168
    4. Reto A. Gadient, Thomas Bühler, Marcel Luyten, N. Rao Movva
      Pages 169-180
  6. Perspectives

  7. Back Matter
    Pages 215-218

About this book

Introduction

Expanding from the classic use of immunosuppressants in transplantation and rejection, this current overview highlights their new roles in clinical medicine. Immunosuppressants are at the forefront of new treatment modalities. Individual chapters focus on their use not only in prevention or treatment of transplant rejection, but also on their use in immune-complex and autoimmune diseases, including rheumatoid arthritis; on combination therapies to achieve synergy in immunosuppression; on new drugs, low molecular weight chemicals, the use of antibodies and gene therapy; on immunological tolerance to prevent or inhibit transplant rejection; and how data derived from transplant studies can be applied to other avenues of immunosuppression. Clinicians and researchers will appreciate the scope of the work and the presentation of new approaches in the rapidly developing field of immunosuppression.

Keywords

autoimmune disease diseases drugs gene therapy immunosuppression medicine research rheumatism therapy transplantation

Editors and affiliations

  • Henk-Jan Schuurman
    • 1
  • Gilles Feutren
    • 2
  • Jean-François Bach
    • 3
  1. 1.Novartis Pharma AGUSA
  2. 2.Novartis Pharma AGBaselSwitzerland
  3. 3.Immunologie CliniqueHôpital NeckerParis Cedex 15France

Bibliographic information

Industry Sectors
Pharma
Health & Hospitals
Biotechnology